Inventiva SA ADR (NASDAQ:IVA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IVA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IVA

  • Market Cap$583.600m
  • SymbolNASDAQ:IVA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS46124U1079

Company Profile

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis and rare diseases. All the company's operations are located in France. The majority of the group's revenue is derived from its research partnerships with AbbVie and BI.Inventiva SA is a France-based clinical stage drug-discovery and development company.

Latest IVA news

Currently there for this company. Visit our news hub for other news .